Kezar Life Sciences, Inc.

Historical 13F Holders

Symbol
KZR
CUSIP
49372L209
All holders as of
Q1 2026
Type
Equity
Class
COM NEW
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 49372L209 since 12/18/2024, newest first.

Filer % of Class Filed
Baselake Partners, LP 13G/A Amendment 2
0% 5/28/2026
Event 5/11/2026
Tang Capital Management LLC 13D/A Amendment 2
0% 5/13/2026
Event 5/11/2026
Baselake Partners, LP 13G/A Amendment 1
0% 5/12/2026
Event 5/11/2026
Baselake Partners, LP 13G
5.3% 4/6/2026
Event 3/30/2026
Tang Capital Management LLC 13D/A Amendment 1
9.0% 4/1/2026
Event 3/30/2026
Stonepine Capital Management, LLC 13G/A Amendment 1
2.1% 2/13/2026
Event 12/31/2025
Avidity Partners Management LP 13G/A Amendment 4
0% 11/14/2025
Event 9/30/2025
Stonepine Capital Management, LLC 13G
5.2% 9/8/2025
Event 9/2/2025

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q1 48 4.48 M $33.2 M
2025 Q4 46 4.51 M $28.4 M
2025 Q3 41 4.24 M $16.5 M
2025 Q2 41 4.47 M $20.5 M
2025 Q1 43 4.33 M $21.1 M
2024 Q4 47 4.20 M $28.2 M
2024 Q3 3 1.44 M $1.11 M
2024 Q2 1 18.3 k $11.0 k